Dr. Fabio Iwamoto, MD
Claim this profileColumbia University Medical Center
Studies Glioblastoma
Studies Relapse
15 reported clinical trials
27 drugs studied
Area of expertise
1Glioblastoma
Stage IV
IDH negative
MET positive
2Relapse
Stage IV
Stage III
MET positive
Affiliated Hospitals
Clinical Trials Fabio Iwamoto, MD is currently running
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
More about Fabio Iwamoto, MD
Clinical Trial Related3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Fabio Iwamoto, MD has experience with
- Nivolumab
- Placebo
- Temozolomide
- IGV-001
- Standard Of Care (SOC): Radiation Therapy
- Tirabrutinib
Breakdown of trials Fabio Iwamoto, MD has run
Glioblastoma
Relapse
Benign Glioma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fabio Iwamoto, MD specialize in?
Fabio Iwamoto, MD focuses on Glioblastoma and Relapse. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are IDH negative.
Is Fabio Iwamoto, MD currently recruiting for clinical trials?
Yes, Fabio Iwamoto, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Fabio Iwamoto, MD has studied deeply?
Yes, Fabio Iwamoto, MD has studied treatments such as Nivolumab, Placebo, Temozolomide.
What is the best way to schedule an appointment with Fabio Iwamoto, MD?
Apply for one of the trials that Fabio Iwamoto, MD is conducting.
What is the office address of Fabio Iwamoto, MD?
The office of Fabio Iwamoto, MD is located at: Columbia University Medical Center, New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.